ise and shine, everyone, another busy day is on the way. We can tell the pace is picking up, if only because our shortest person has grabbed the bus for the local schoolhouse as another dizzying year of learning gets under way. This calls for a celebratory cup of stimulation. Feel free to join us. Now, of course, it is time to get cracking. So here are a few items of interest. Hope your day goes well and do keep in touch …

The percentage of U.S. adults under age 65 who skip essential medicines due to price has declined, Reuters reports, citing a study in the Journal of the National Cancer Institute. But problems with financial access to medication were consistently more common in cancer survivors. In each of the six years studied, cancer survivors were more likely to report forgoing prescription drugs in the past year because of cost.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Manchester, and all these New England communities are on shaky legal ground. They have gone on record as stating that the opiate epidemic is NOT a prescription drug problem. Most of the overdose deaths are from heroin and fentanyl from the Sinaloa Mexican drug cartel. So if they want to sue anyone they should go after El Chapo. He probably has more money than Purdue anyway.

  • What did the psalmist say?
    “Seventy is the sum of our years, or eighty if we are strong”
    … unless one volunteers for a Cellectis clinical trial.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy